Screening of Lyngbya majuscula for potential antibacterial activity and HPTLC analysis of active methanolic extract

Journal of Pure and Applied Microbiology

Volumn 3, Issue 1, 2009, Pages 169-174

  Kaushik, P ^a   Garima, ^a   Chauhan, Abhishek ^a   Goyal, Pankaj ^a  

^a GURUKUL KANGRI UNIVERSITY   (India)

Author keywords

Antimicrobial activity; Cyanobacteria; HPTLC; Lyngbya majuscula; Minimum inhibitory concentration

Indexed keywords

ACETIC ACID ETHYL ESTER; ANTIINFECTIVE AGENT; HEXANE; LYNGBYA MAJUSCULA EXTRACT; METHANOL; NYSTATIN; PLANT EXTRACT; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS CEREUS; BACILLUS SUBTILIS; BACTERIUM CULTURE; BROTH DILUTION; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISK DIFFUSION; DRUG DETERMINATION; DRUG SCREENING; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; LYNGBYA MAJUSCULA; METABOLITE; MICROBIAL BIOMASS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS EPIDERMIDIS; SUPERNATANT;

BACILLUS CEREUS; BACILLUS SUBTILIS; CANDIDA ALBICANS; CYANOBACTERIA; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; LYNGBYA MAJUSCULA; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 79960746956     PISSN: 09737510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hagmann, L. and Juttner, F. Fischerellin A., a novel photosystem-II-inhibiting alleochemical of the cyanobcterium Fischerella muscicola with antifungal and herbicidal activity. Tetrahedron Lett., 1996; 37: 6539-6542.
2. Mundt, S., Kreitlow, S., Nowotny A. and Effmert U. Biological and pharmacological investigation of selected cyanobacteria. Int J Hyg Environ Health., 2001; 203: 327-334
3. Falch, B.S., Konig, G.M., Wright, A.D., Sticher, O., Angerhofer, C.K., Pezzuto, J.M., Bachmann, H. Biological activities of cyanobacteria: Evaluation of extracts and pure compounds. Planta Med., 1995; 61: 321-328.
4. Kaushik, P. and Chauhan, A. In vitro antibacterial activity of laboratory grown culture of Spirulina platensis. Ind J Microbiol., 2008; 48(3): 348-352.
5. Kaushik, P., Chauhan, A., Chauhan, G, Goyal, P. Evaluation of Nostoc commune for potential antibacterial activity and UV-HPLC analysis of methanol extract. The Internet Journal of Microbiology., 2008; 5(1).
6. Asthana, R.K., Srivastava, A., Singh, A.P., Deepali, Singh, S.P., Nath, G., Srivastava, R. and Srivastava, B.S. Identification of an antimicrobial entity from the cyanobacterium Fischerella sp. isolated from bark of Azadirachta indica (Neem) tree. Journal of Applied Phycology., 2006; 18(1): 33-39.
7. Rao, M., Malhotra, S., Fatma, T. and Rattan, A. Antimycobacterial activity from cyanobacterial extracts and phytochemical screening of methanol extract of Hapalosiphon. Pharma Biol., 2007; 45: 88-93
8. Kellam, S.J., Cannell, R.J.P., Owsianka, A.M., and Walker, J.M. Results of large-scale screening programme to detect antifungal activity from marine and fresh water microalgae in laboratory culture. Brit Phycol J., 1988; 23: 45-47.
9. MacMillan, J.B., Ernst-Russell, M.A., De Ropp J.S., Molinski, T.F. Lobocyclamides A-C, lipopeptides from a cryptic cyanobacterium mat containing Lyngbya confervoides. J. Org. Chem., 2002; 67: 8210-8215.
10. Kashiwagi, S., Mynderse, J.S., Moore, R.E. and Norton, T.R. Antineoplastic evaluation of Pacific basin marine algae. J. Pharmaceutical Sciences., 1980; 69: 735-738
11. Carmeli, S., Moore, R.E. and Patterson, G.M.L. Isonitriles from the blue green alga Scytonema mirabile, J. Org. Chem., 1990; 55: 4431-8.
12. Gustafson, K.R., Sowder, R., Henderson, L., Pannel, L., Cardellina, J., McMahon, J., Shoe Maker, R. and Boyd, M. Sequence determination and chemical characteristics of a novel anti-HIV protein, cyanovirin-N, isolated from the cyanobacterium Nostoc ellipsosporum. Int Cont. AIDS., 1996; 11: 70.
13. Hayashi, T., Hayashi, K. Calcium spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis. J. Nat. Prod., 1996; 59: 83-87.
14. Cannell, R.J.P., Kellam, S.I., Owsianka, A.M. and Walker, J.M. Microalgae and cyanobacteria as a source of glycosidase inhibitors. J. Gen Microbiol., 1987; 133: 1701-1705
15. Borowitzka, M.A.. Microalgae as a source of pharmaceuticals and other biologically active compounds. J. Appl. Phycol., 1995; 7: 3-15.
16. Falch, B. Was steckt in cyanobakterien? Pharmazie in unserer Zeit., 1996; 25: 311-321.
17. Trias, J., Gorden, E.M.. Innovative approaches to novel antibacterial drug discovery. Curr. Opin. Biotech. 1997; 8: 757-762.
18. Stanier, R.Y., Kunisawa, R., Mandel, M., Cohen, B.G. Purification and properties of unicellular blue-green algae (Order-chrococales). Bact Rev., 1971; 35: 171-205.
19. Ghasemi, Y., Yazdi, M.T., Shafiee, A., Amini, M., Shokravi, S. and Zarrini, G. Antifungal and antibacterial activity of paddy-fields cyanobacteria from the north of Iran. J Sciences., 2003; 14: 203-209
20. Indian Pharmacopoeia. Microbiological assay of antibiotics (2.2.10). The Indian Pharmacopoeia Commission, Central Indian-Pharmacopoeia Laboratory, Government of India, Ministry of Family Welfare, Ghazi bad, 201002. 2007.
21. Kirby, W.M.M., Bauer, A.W. Antibiotic susceptibility testing by a standardized single disc method. J Clin Pathol., 1966;45: 493
22. NCCLS-National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility tests for Bacteria that Grow Aerobically, Approved Standard M7-A4, Wayne, 1977a.